Abbott Laboratories (ABT) Dividends payables (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Dividends payables data on file, last reported at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Dividends payables rose 6.59% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 6.59% YoY), and the FY2025 full-year result was $1.1 billion, up 7.13% from the prior year.
• Dividends payables was little changed at $1.1 billion in Q1 2026, from $1.1 billion in the prior quarter.
• In the past five years, Dividends payables ranged from a high of $1.1 billion in Q1 2026 to a low of $820.0 million in Q3 2022.
• A 5-year average of $950.4 million and a median of $956.0 million in 2024 frame the typical range for Dividends payables.
• Across the five-year window, Dividends payables advanced 2.87% in 2022 and rose 8.24% in 2024, its largest moves.
• Tracing ABT's Dividends payables over 5 years: stood at $887.0 million in 2022, then grew by 7.67% to $955.0 million in 2023, then grew by 7.23% to $1.0 billion in 2024, then climbed by 7.13% to $1.1 billion in 2025, then increased by 0.27% to $1.1 billion in 2026.
• Business Quant data shows ABT's Dividends payables at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.0 billion in Q3 2025.